Family Management Corp Purchases New Shares in Humana Inc. (NYSE:HUM)

Family Management Corp bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 12,690 shares of the insurance provider's stock, valued at approximately $3,134,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares in the last quarter. Dodge & Cox grew its stake in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Pzena Investment Management LLC boosted its stake in shares of Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the period. Geode Capital Management LLC grew its stake in shares of Humana by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after acquiring an additional 63,562 shares in the last quarter. Finally, Invesco Ltd. raised its position in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after purchasing an additional 550,692 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HUM. Guggenheim initiated coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target for the company. Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Truist Financial raised their price target on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research note on Friday, April 11th. Finally, Oppenheimer raised their price objective on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Seventeen research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $287.76.

Humana Stock Down 1.5 %

HUM stock traded down $3.68 during mid-day trading on Friday, reaching $249.67. 1,087,102 shares of the company traded hands, compared to its average volume of 1,745,516. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $30.13 billion, a price-to-earnings ratio of 25.09, a P/E/G ratio of 2.05 and a beta of 0.49. The firm's 50 day moving average price is $265.21 and its 200 day moving average price is $270.38. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The company had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the company posted $7.23 EPS. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.42%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.